Team:Fatih-Medical

From 2012.igem.org

(Difference between revisions)
 
(23 intermediate revisions not shown)
Line 1: Line 1:
{{Template:Fatih-header}}
{{Template:Fatih-header}}
 +
<html>
 +
        <div class="wrapper">
 +
          <div class="box_skitter box_skitter_large" style="margin-left: auto; margin-right: auto; margin-bottom: 50px; ">
 +
    <ul>
 +
        <li>
 +
            <a href="https://2012.igem.org/Team:Fatih-Medical"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926185714!Sherlocoli_Overview_%281%29.png" class="block" /></a>
-
        <div class="wrapper">
+
            <div class="label_text">
 +
                <p>Meet Fatih Medical 2012</p>
 +
            </div>
 +
        </li>
-
        <article class="grid_8">
+
        <li>
-
            <div class="padding-left">
+
            <a href="https://2012.igem.org/Team:Fatih-Medical/Project"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926112144!Sherlocoli_Overview_%281%29.png" class="block" /></a>
-
                <h2>CANCEL the CANCER: A SynBio Approach to the Early Diagnosis of Cancer </h2>
+
            <div class="label_text">CTC Project At A Glance</div>
-
<HR size="10" width="70%" align="left">
+
        </li>
 +
        <li>
 +
            <a href="https://2012.igem.org/Team:Fatih-Medical/Human_Practice"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926112229!Sherlocoli_Overview_%281%29.png" class="block" /></a>
-
                 </div>
+
            <div class="label_text">
-
             </article>
+
                 <p>Challenge Accepted! Here's The Video!</p>
 +
             </div>
 +
        </li>
-
             <article class="grid_15">
+
        <li>
-
  Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.
+
             <a href="https://2012.igem.org/Team:Fatih-Medical/Human_Practice/Secret_Book"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926112309!Sherlocoli_Overview_%281%29.png" class="block" /></a>
-
 
+
-
            </article>
+
-
        </div>
+
 +
            <div class="label_text">
 +
                <p>Gorgeous Surprises From FM For All iGEMers </p>
 +
            </div>
 +
        </li>
-
<div class="wrapper padding-top">
+
        <li>
 +
            <a href="https://2012.igem.org/Team:Fatih-Medical/Human_Practice"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926113241!Sherlocoli_Overview_%281%29.png" class="block" /></a>
-
<div class="grid_9">
+
            <div class="label_text">
-
<img width="310" class="padding-left" src="https://static.igem.org/mediawiki/2012/4/48/Fatih-Dj.png">
+
                <p>iGEM For Everyone!</p>
-
</div>
+
            </div>
 +
        </li>
-
<div class="grid_14 padding-top">
+
        <li>
-
Bla-bla-bla.. Bla-bla. <a href="#">Project page</a>
+
            <a href="https://2012.igem.org/Team:Fatih-Medical/Lab/Gallery"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926114250!Sherlocoli_Overview_%281%29.png" class="block" /></a>
-
</div>
+
-
</div>
+
 +
            <div class="label_text">
 +
                <p>Various Times, Various Memories</p>
 +
            </div>
 +
        </li>
 +
        <li>
 +
            <a href="http://fatih.edu.tr/"><img src="https://static.igem.org/mediawiki/2012/archive/f/f7/20120926113840!Sherlocoli_Overview_%281%29.png" class="block" /></a>
 +
            <div class="label_text">
 +
                <p>Fatih University Campus</p>
 +
            </div>
 +
        </li>
 +
    </ul>
 +
</div>
 +
        </div>
 +
        <div class="wrapper">
-
    </div>
+
            <article class="grid_12">
-
</section>
+
<map id="imgmap201292712257" name="imgmap201292712257"><area shape="rect" alt="" title="" coords="26,7,401,169" href="https://2012.igem.org/Team:Fatih-Medical/Sherlocoli" target="" /><area shape="rect" alt="" title="" coords="26,179,405,345" href="https://2012.igem.org/Team:Fatih-Medical/DJcoli" target="" /><area shape="rect" alt="" title="" coords="24,357,405,528" href="https://2012.igem.org/Team:Fatih-Medical/Dracoli" target="" /><!-- Created by Online Image Map Editor (http://www.maschek.hu/imagemap/index) --></map>
 +
<img usemap="#imgmap201292712257" src="https://static.igem.org/mediawiki/2012/6/66/Fatih-home-icons.png">
 +
            </article>
 +
 +
            <article class="grid_12">
 +
<h2>Cancel the Cancer: A SynBio Approach to the Early Diagnosis of Cancer </h2>
 +
<HR size="10" width="70%" align="left">
 +
  Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.
 +
 
 +
            </article>
 +
        </div>
-
</div>
 
-
</div>
 
-
</div>
 
-
</div>
 
-
<footer>
 
-
<div class="main">
 
-
        <div class="fright"><!-- {%FOOTER_LINK} --></div>
 
-
        Fatih Medical © 2012 &nbsp;| &nbsp;<a href="index-6.html">Privacy Policy</a>
 
-
    </div>
 
-
</footer>
 
-
</body>
 
</html>
</html>
 +
{{Template:Fatih-footer}}

Latest revision as of 00:44, 27 September 2012

  • Meet Fatih Medical 2012

  • CTC Project At A Glance

  • Challenge Accepted! Here's The Video!

  • Gorgeous Surprises From FM For All iGEMers

  • iGEM For Everyone!

  • Various Times, Various Memories

  • Fatih University Campus

Cancel the Cancer: A SynBio Approach to the Early Diagnosis of Cancer

Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.
Fatih Medical © 2012  

Retrieved from "http://2012.igem.org/Team:Fatih-Medical"